The January/February issue of Departures Magazine contains a feature called “The State of Plastic Surgery 2012″. The magazine covers topics such as how to find the best plastic surgeon, the use of stem cells in plastic surgery and the best hair loss therapies.
The section on hair loss offers a timeline of the major advances in the treatment of hair loss since its inception over 75 years ago.
Posted by Updated 2014-03-11
Latisse, which is the brand name for the drug bimatoprost, has been found to effectively and safely grow eyelashes in a double-blinded scientific study published in the May 2012 issue of the Journal of the American Academy of Dermatology.
Q: I saw your post on the clinical trials of Latisse (bimatoprost) for hair loss on the scalp. What is the status of the study? — B.V., New Providence, NJ
A: Allergan, the company that makes Latisse, is conducting safety and efficacy testing of three formulations of the drug for men with androgenetic alopecia (male pattern baldness).
Posted by Updated 2020-03-04Latisse, the brand name for the drug bimatoprost, is commonly used to promote eyelash growth in women who want their eyelashes to be longer, thicker, and darker, typically for cosmetic reasons.
In a publication on ClinicalTrials.gov, Allergan, the pharmaceutical company that produces Latisse, has announced a new study on the safety and efficacy of a new formulation of bimatoprost for use as a topical hair loss treatment for general baldness.
Posted by Updated 2020-03-04